US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
BioStem Technologies, Inc. - Common Stock
(NQ:
BSEM
)
2.730
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioStem Technologies, Inc. - Common Stock
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
↗
August 21, 2026
BioStem Technologies (OTCMKTS:BSEM) outlined its strategy to expand in surgical applications, shift its revenue mix away from physician-office wound care and bring manufacturing of acquired products...
Via
MarketBeat
BioStem Technologies Q2 Earnings Call Highlights
↗
August 13, 2026
BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from...
Via
MarketBeat
Topics
Earnings